Test Bank | Applied Pharmacology for the Dental Hygienist 9th Edition | Elena Bablenis Haveles | Verified Questions & Correct Answers | Updated 2025 | A+ Graded

AppliedPharmacology forTheDentalHygienist9th
w1 w1 w1 w1 w1 w1




Edition by Elena Bablenis Haveles
w1 w1 w1 w1 w1




CompleteTestBank1
w 1
w

,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription Writing
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




Haveles:AppliedPharmacology forthe Dental Hygienist,9thEdition
w
1 w
1 w1 w
1 w
1 w1 w
1 w
1




MULTIPLE CHOICE w1




1. Knowledge of pharmacology aids the dental professional in w1 w1 w1 w1 w1 w1 w1




a. obtaining a patient’s health history. w1 w1 w1 w1




b. administering drugs in the office. w1 w1 w1 w1




c. handling emergency situations. w1 w1




d. selection of a nonprescription medication. w1 w1 w1 w1




e. All of the above. w1 w1 w1




ANS: w 1 E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




pharmacology helps in understanding and interpreting patients’ responses to health history questions.
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




knowledge of pharmacology is of great help, especially because a rapid response is sometimes required. A
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




clear understanding of the concepts of drug action, drug handling by the body, and drug interactions will
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




allow the dental practitioner to make proper judgments and grasp the concepts relevant to new drug
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




therapies on the market.
w1 w1 w1 w1




DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
w 1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




(Nonprescription Medication) | pp. 2-3
w1 OBJ: 1 w1 w1 w1 w1




TOP: NBDHE, 6.0. Pharmacologyw 1 w1 w1




2. Which of the following statements is true regarding planning appointments?
w1 w1 w1 w1 w1 w1 w1 w1 w1




a. Whether or not patients are taking medication for systemic diseases is of little w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




consequence in the dental office. w1 w1 w1 w1




b. Asthmatic patients should have dental appointments in the morning. w1 w1 w1 w1 w1 w1 w1 w1




c. Diabetic patients usually have fewer problems with a morning appointment w1 w1 w1 w1 w1 w1 w1 w1 w1




compared with afternoon appointments.
w1 w1 w1 w1




d. Both B and C are true. w1 w1 w1 w1 w1




ANS: w 1 D
Asthmatic patients who experience dental anxiety should schedule their appointments when they are not
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




with a morning appointment. Patients taking medication for systemic diseases may require special
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




handling in the dental office.
w1 w1 w1 w1 w1




DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3
w 1 w1 w1 w1 w1 w1 w1 w1 w1 w1




OBJ: 1
w1 TOP: NBDHE, 6.0. Pharmacology
w 1 w 1 w1 w1

,3. Nutritional or herbal supplements w1 w1 w1




a. carry the U.S. Food and Drug Administration (FDA) approval for disease states.
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




b. are not drugs. w1 w1




c. can cause adverse effects. w1 w1 w1




d. will not interact with other drugs the patient may be taking.w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




ANS: w 1 C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional or w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




herbal supplements do not carry FDA approval for treating disease states. These supplements are drugs and
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




can cause adverse effects and interact with different drugs.
w1 w1 w1 w1 w1 w1 w1 w1 w1




DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | p. 3
w 1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




OBJ: 1
w1 TOP: NBDHE, 6.0. Pharmacology
w 1 w 1 w1 w1




4. Which type of drug name usually begins with a lowercase letter?
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




a. Brand name w1




b. Code name w1




c. Generic name w1




d. Trade name w1




ANS: w 1 C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the drug. Each
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is not
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name is
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




technically the name of the company marketing the product, this term is often used interchangeably with the
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




trade name. The code name is the initial term used within a pharmaceutical company to refer to a drug
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




while it is undergoing investigation and is often a combination of capital letters and numbers, the letters
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




representing an abbreviation of the company name.
w1 w1 w1 w1 w1 w1 w1




DIF: Comprehension REF: Drug Names | p. 4 w 1 w1 w1 w1 w1




OBJ: 3
w1 TOP: w 1 w 1 NBDHE, 6.0. Pharmacology w1 w1




5. A drug’s generic name is selected by the
w1 w1 w1 w1 w1 w1 w1




a. pharmaceutical company manufacturing it. w1 w1 w1




b. Food and Drug Administration (FDA). w1 w1 w1 w1




c. U.S. Adopted Name Council. w1 w1 w1




d. Federal Patent Office. w1 w1




ANS: w 1 C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




company manufacturing the drug clearly has an influence on the generic name given its drug, but the final
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




decision is not the company’s.
w1 w1 w1 w1 w1




DIF: Recall REF: Drug Names | p. 4 w 1 w1 w1 w1 w1 OBJ:
w3 TOP: NBDHE, 6.0. Pharmacology
1 w1 w 1 w1 w1




6. Which of the following is true concerning generic and trade names of drugs?
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




a. A drug may only have one generic name and one trade name.
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1

, b. A drug may only have one generic name, but it may have several trade names.
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




c. A drug may have several generic names, but it may only have one trade name.
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




d. A drug may have several generic names and several trade names.
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




ANS: w 1 B
Each drug has only one generic name but may have several trade names. For each drug, there is only one
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




generic name. It is not capitalized, and it becomes the “official” name of the drug. The pharmaceutical
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




company discovering the drug gives the drug a trade name. The trade name is protected by the Federal
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




Patent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




brand name is technically the name of the company marketing the product, it is often used interchangeably
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




with the trade name.
w1 w1 w1 w1




DIF: Comprehension REF: Drug Names | p. 4 w 1 w1 w1 w1 w1




OBJ: 3
w1 TOP: w 1 w 1 NBDHE, 6.0. Pharmacology w1 w1




7. Two drugs that are found to be chemically equivalent, but not biologically equivalent or
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




w1 therapeutically equivalent are said to differ in w1 w1 w1 w1 w1 w1




a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. w1




ANS: w 1 C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




products are said to differ in their bioavailability. The potency of a drug is a function of the amount of drug
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




required to produce an effect. The efficacy is the maximum intensity of effect or response that can be
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




animals divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




index is small, toxicity is more likely.
w1 w1 w1 w1 w1 w1 w1




DIF: Recall REF: w 1 Drug Names (Drug Substitution) | p. 5 w1 w1 w1 w1 w1 w1




OBJ: 4
w1 w 1 TOP: w 1 NBDHE, 6.0. Pharmacology w1 w1




8. How many years must pass after a drug patent expires before other drug companies can market the same
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




compound as a generic drug?
w1 w1 w1 w1 w1




a. 20 years w1




b. 17 years w1




c. 7 years w1




d. 0 years w1




ANS: w 1 D
Once a drug patent expires, competing companies may immediately market the same compound in
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The trade
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus the patent
w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1 w1




term extensions.
w1 w1




DIF: Application REF: w 1 Drug Names (Drug Substitution) | p. 5 w1 w1 w1 w1 w1 w1




OBJ: 4
w1 w 1 TOP: w 1 NBDHE, 6.0. Pharmacology w1 w1